YorLabs Overview
- Year Founded
-
2015

- Status
-
Private
- Employees
-
26

- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$17.3M
- Investors
-
4
YorLabs General Information
Description
Developer of an advanced, compact ultrasound system intended to offer image guidance of intra-cardiac medical procedures. The company's device infuses ultrasound systems with artificial intelligence, enabling practitioners to read images and diagnose patients.
Contact Information
Website
www.yorlabs.comCorporate Office
- 9255 South West Nimbus Avenue
- Beaverton, OR 97008
- United States
Corporate Office
- 9255 South West Nimbus Avenue
- Beaverton, OR 97008
- United States
YorLabs Timeline
YorLabs Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Later Stage VC (Series C) | 31-Oct-2023 | $17.3M | Completed | Generating Revenue | ||
3. Later Stage VC (Series B) | 08-Nov-2021 | Completed | Generating Revenue | |||
2. Debt - PPP | 13-Apr-2020 | $345K | $5.35M | Completed | Generating Revenue | |
1. Early Stage VC (Series A) | 07-Oct-2019 | $5.35M | $5.35M | Completed | Startup |
YorLabs Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | ||||||||
Series B.2 | ||||||||
Series B.1 | 2,058,186 | 3% | $6.31 | $6.31 | 1x | $6.31 | 18.26% | |
Series A | 847,639 | 3% | $4.13 | $4.13 | 1x | $4.13 | 7.52% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
YorLabs Patents
YorLabs Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-12156761-B1 | Bayesian anatomically-driven, artificial-intelligence based intracardiac echocardiography object detection and prediction | Active | 05-Mar-2024 | ||
US-20240324996-A1 | Flex interconnect for a transducer array on an intracardiac echocardiography catheter device | Pending | 27-Mar-2023 | ||
US-20240266045-A1 | Ice ultrasound remote control | Pending | 02-Feb-2023 | ||
US-20240265512-A1 | Systems and methods for automatic suppression of comet tail artifacts in b-mode images of an intracardiac ablation catheter | Pending | 02-Feb-2023 | ||
US-20230059122-A1 | Orthogonally oriented steering controls for ice catheter | Pending | 17-Aug-2021 | A61M25/0136 |
YorLabs Signals
YorLabs Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Globaleye Ventures | Venture Capital | Minority | ||
ShangBay Capital | Venture Capital | Minority | ||
TiE Oregon | Accelerator/Incubator | Minority | ||
Vectr Ventures | Venture Capital | Minority |
YorLabs FAQs
-
When was YorLabs founded?
YorLabs was founded in 2015.
-
Where is YorLabs headquartered?
YorLabs is headquartered in Beaverton, OR.
-
What is the size of YorLabs?
YorLabs has 26 total employees.
-
What industry is YorLabs in?
YorLabs’s primary industry is Diagnostic Equipment.
-
Is YorLabs a private or public company?
YorLabs is a Private company.
-
What is the current valuation of YorLabs?
The current valuation of YorLabs is
. -
What is YorLabs’s current revenue?
The current revenue for YorLabs is
. -
How much funding has YorLabs raised over time?
YorLabs has raised $37.7M.
-
Who are YorLabs’s investors?
Globaleye Ventures, ShangBay Capital, TiE Oregon, and Vectr Ventures have invested in YorLabs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »